REGENXBIO Inc.RGNX
KeepKeep what you own, but don't buy more for now.
- 3 good· Earnings beat
- 3 to watch· Far below its high
$8.11−0.36 (−4.25%)
Price at 3:03 PM ET
After hours · opens in 17h 23mNext open: Friday, Nov 13, 9:30 AM ETNASDAQ · Healthcare · Small company
Read the full report on RGNX with a free account
The full report adds the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.
What would change it
Sources
- Yahoo Finance daily closes to Nov 9
Any one could move it to Sell some
Compared with the S&P 500
21 points
worse in one day
46 points
worse in five trading days
−26.4% in a yearsince Nov 10, 2025
Latest results
Reported Nov 5 before the open
- EPS
- −$0.62
- vs −$1.35 expected, beat by 54%
- The stock
- −4.3%
- On Nov 5, usually 4%
The news behind our call
written Oct 14, 10:32 AM ETOct 14, 10:32 AM ET · 3 articles · 3 sources
What changed
From Yahoo Finance, REGENXBIO Inc. via Yahoo Finance and Yahoo Finance UK
RGNX reported earnings on Nov 5.
Overview
In plain numbers
- Revenue fell 4.6% from a year earlier, to $153.9M in the last twelve months.
- It loses $1.20 on every revenue dollar at the operating line, down from 34 cents in FY 2021.
- It burned $154.8M of free cash in the last twelve months.
- It owes $252.2M and holds $251.0M in cash and investments, so net debt is $1.3M.
Key figures
- Revenue (TTM)
- $154M
- Revenue growth, 1 year
- −4.6%
- Net income
- −$175M
- EPS (diluted)
- −$3.15
- Gross margin
- -64.5%
- Operating margin
- -120.4%
- Return on equity
- -113.2%
- Return on capital
- -101.3%
- Debt / equity
- 1.70
- Current ratio
- 4.74
- Buyback yield
- -8.27%
Key facts
- Company value
- $504M
- Today's range
- 7.948.33
- Past year's range
- 5.6515.98
- Yesterday's close
- $8.47